As US FTC Again Targets Cannabinoid Advertising, 2 Commissioners Approve With Caution
Executive Summary
FTC announced settlements with six firms 15 months said it was done warning about false and misleading ad claims for supplements and other consumer health products containing cannabidiols and cannabinoids and would start filing complaints.
You may also be interested in...
OTC Decisions November-December: GSK Labels For Nexium Promotion, Voltaren 2-Pack Approved
Approvals by FDA also include revised container and consumer information labeling for J&J's Men’s Rogaine to align with labeling for Women’s Rogaine; bonus-pack labeling for Bayer AG’s Aleve; and
J&J CEO: COVID-19 ‘Demonstrated Importance of Self-Care Overall’
During JP Morgan conference, Alex Gorsky suggests responding to pandemic is changing health care, including businesses providing pharmaceuticals, medical technologies, nutritionals and other necessary products.
Hand Sanitizer Problems Prompt US FDA Guidance On Keeping Methanol Out Of Other OTC Drugs
Final guidance, for pharmaceutical alcohol used as an active or inactive ingredient in other drugs as well as hand sanitizers, “will help pharmaceutical manufacturers avoid using pharmaceutical alcohol contaminated with or substituted with methanol in drug products.”
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: